Literature DB >> 10531301

A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain.

T Suzuki1, A Ichiyama, H Saitoh, T Kawakami, M Omata, C H Chung, M Kimura, N Shimbara, K Tanaka.   

Abstract

SUMO-1 is a ubiquitin-like protein functioning as an important reversible protein modifier. To date there is no report on a SUMO-1 hydrolase/isopeptidase catalyzing the release of SUMO-1 from its precursor or SUMO-1-ligated proteins in mammalian tissues. Here we found multiple activities that cleave the SUMO-1 moiety from two model substrates, (125)I-SUMO-1-alphaNH-HSTVGSMHISPPEPESEEEEEHYC and/or GST-SUMO-1-(35)S-RanGAP1 conjugate, in bovine brain extracts. Of them, a major SUMO-1 C-terminal hydrolase had been partially purified by successive chromatographic operations. The enzyme had the ability to cleave SUMO-1 not only from its precursor but also from a SUMO-1-ligated RanGAP1 but did not exhibit any significant cleavage of the ubiquitin- and NEDD8-precursor. The activity of SUMO-1 hydrolase was almost completely inhibited by N-ethylmaleimide, but not by phenylmethanesulfonyl fluoride, EDTA, and ubiquitin-aldehyde known as a potent inhibitor of deubiquitinylating enzymes. Intriguingly, the apparent molecular mass of the isolated SUMO-1 hydrolase was approximately 30 kDa, which is significantly smaller than the recently identified yeast Smt3/SUMO-1 specific protease Ulp1. These results indicate that there are multiple SUMO-1 hydrolase/isopeptidases in mammalian cells and that the 30-kDa small SUMO-1 hydrolase plays a central role in processing of the SUMO-1-precursor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531301     DOI: 10.1074/jbc.274.44.31131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.

Authors:  J Parkinson; R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner.

Authors:  Hideki Murakami; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-08

4.  SUMOylation of Pax7 is essential for neural crest and muscle development.

Authors:  Zhidong Luan; Ying Liu; Timothy J Stuhlmiller; Jonathan Marquez; Martín I García-Castro
Journal:  Cell Mol Life Sci       Date:  2012-12-18       Impact factor: 9.261

5.  SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis.

Authors:  Luyang Yu; Weidong Ji; Haifeng Zhang; Matthew J Renda; Yun He; Sharon Lin; Ee-chun Cheng; Hong Chen; Diane S Krause; Wang Min
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

6.  Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.

Authors:  Stuart J Netherton; Shirin Bonni
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

7.  SUMOylation of the GTPase Rac1 is required for optimal cell migration.

Authors:  Sonia Castillo-Lluva; Michael H Tatham; Richard C Jones; Ellis G Jaffray; Ricky D Edmondson; Ronald T Hay; Angeliki Malliri
Journal:  Nat Cell Biol       Date:  2010-10-10       Impact factor: 28.824

8.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.

Authors:  Sha Tian; Hetti Poukka; Jorma J Palvimo; Olli A Jänne
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

9.  DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.

Authors:  Jinah Park; Tae-You Kim; Yeonjoo Jung; Sang-Hyun Song; Sung-Hak Kim; Do-Youn Oh; Seock-Ah Im; Yung-Jue Bang
Journal:  J Mol Med (Berl)       Date:  2008-09-02       Impact factor: 4.599

10.  Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.

Authors:  Joris Hemelaar; Anna Borodovsky; Benedikt M Kessler; David Reverter; Julie Cook; Nagamallesawari Kolli; Tudev Gan-Erdene; Keith D Wilkinson; Grace Gill; Christopher D Lima; Hidde L Ploegh; Huib Ovaa
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.